Expression of cytotoxic T lymphocyte-associated antigen 4, CD44, and E-cadherin in the microenvironment of breast carcinomas.
Tugce Bolme SavliHüsniye Esra PaşaoğluTaha Cumhan SavliAli MuhammedogluMerve TokocinÇiğdem ÖztürkPublished in: Revista da Associacao Medica Brasileira (1992) (2023)
Tumor budding could predict poor prognosis in breast carcinomas, and anti-cytotoxic T lymphocyte-associated antigen 4 immunotherapies may be beneficial in patients with high tumor budding tumors.